Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (1-10 of 415) with videos related to

Pageof 42
Sort By:
Revue Medicale Suisse|October 21, 2024
Alexandra Calmy
The Lancet. Infectious Diseases|December 5, 2017
Time to overcome pretreatment HIV drug resistanceSabine Yerly, Alexandra Calmy
The Lancet. HIV|October 2, 2015
Is monotherapy maintenance the way forward?Alexandra Calmy, Delphine Sculier
Revue Medicale Suisse|April 8, 2015
[Management of HIV/ AIDS in 2015]Mathieu Rougemont, Alexandra Calmy
Revue Medicale Suisse|March 25, 2015
[What's new in HIV in 2014?]Delphine Sculier, Alexandra Calmy
Lancet (London, England)|July 13, 2010
Treatment of HIV infection with drugs for HSV-2 infectionAngela Huttner, Alexandra Calmy
Expert Opinion on Pharmacotherapy|May 19, 2012
Expert reviews: who are they for?Nathan Ford, Alexandra Calmy
The New England Journal of Medicine|May 16, 2008
Initial treatment for HIV infection--an embarrassment of richesBernard Hirschel, Alexandra Calmy
The Pediatric Infectious Disease Journal|May 22, 2012
Efavirenz is not a known teratogenNathan Ford, Alexandra Calmy
Current Opinion in HIV and AIDS|January 5, 2010
Improving first-line antiretroviral therapy in resource-limited settingsNathan Ford, Alexandra Calmy
Pageof 42

Showing results (1-10 of 415) with videos related to

Sort By:
Pageof 42
Revue Medicale Suisse|October 21, 2024
Alexandra Calmy
The Lancet. Infectious Diseases|December 5, 2017
Time to overcome pretreatment HIV drug resistanceSabine Yerly, Alexandra Calmy
The Lancet. HIV|October 2, 2015
Is monotherapy maintenance the way forward?Alexandra Calmy, Delphine Sculier
Revue Medicale Suisse|April 8, 2015
[Management of HIV/ AIDS in 2015]Mathieu Rougemont, Alexandra Calmy
Revue Medicale Suisse|March 25, 2015
[What's new in HIV in 2014?]Delphine Sculier, Alexandra Calmy
Lancet (London, England)|July 13, 2010
Treatment of HIV infection with drugs for HSV-2 infectionAngela Huttner, Alexandra Calmy
Expert Opinion on Pharmacotherapy|May 19, 2012
Expert reviews: who are they for?Nathan Ford, Alexandra Calmy
The New England Journal of Medicine|May 16, 2008
Initial treatment for HIV infection--an embarrassment of richesBernard Hirschel, Alexandra Calmy
The Pediatric Infectious Disease Journal|May 22, 2012
Efavirenz is not a known teratogenNathan Ford, Alexandra Calmy
Current Opinion in HIV and AIDS|January 5, 2010
Improving first-line antiretroviral therapy in resource-limited settingsNathan Ford, Alexandra Calmy
Pageof 42